Literature DB >> 19718535

Serum immunoglobulin G, M and IgG:IgM ratio as predictors for outcome of childhood nephrotic syndrome.

Ranjit Ranjan Roy1, Eliza Roy, Mohammed Habibur Rahman, Mohammed Moazzam Hossain.   

Abstract

BACKGROUND: Nephrotic syndrome is an immune mediated disorder of the kidney associated with T cell dysfunction and secondary disturbance of B cell with changes in levels of immunoglobulin and IgG:IgM ratio. These changes in immunoglobulin levels can be used as a proxy marker to understand the clinical variety and prognosis of nephrotic syndrome.
METHODS: We studied 43 children with nephrotic syndrome during January 2003 to January 2005 in the Pediatric Nephrology Unit, Department of Pediatrics, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh. Blood samples were collected from the 43 patients, and serum levels of IgG, IgM and IgG:IgM were measured by liquid phase immunoprecipitation assay. Another 20 healthy children attending the laboratory for blood grouping and hepatitis B screening test were enrolled as controls.
RESULTS: In the 43 children with nephrotic syndrome, 24 had steroid sensitive nephrotic syndrome (SSNS) and 19 steroid resistant nephrotic syndrome (SRNS). Compared with healthy children, the IgG level was low, IgM level was high, and IgG:IgM ratio was low (P<0.05). The serum IgG level and IgG:IgM ratio were significantly lower in children with SRNS and in children with frequent relapse (FRNS) combined with steroid dependent nephrotic syndrome (SDNS) than in those with infrequent relapse nephrotic syndrome (IFRNS) (P<0.05, respectively).
CONCLUSIONS: Management of different nephrotic syndromes is based on the levels of immunoglobulins along with clinical and biochemical parameters. The decrease of IgG level as a predictive marker for unfavorable prognosis of nephrotic syndrome in children needs further evaluation in larger scale studies.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19718535     DOI: 10.1007/s12519-009-0025-2

Source DB:  PubMed          Journal:  World J Pediatr            Impact factor:   2.764


  25 in total

Review 1.  [New insights about immunopathology of lipoid nephrosis].

Authors:  Djillali Sahali; Phillippe Lang; Georges Guellaen; Albert Bensman
Journal:  Bull Acad Natl Med       Date:  2002       Impact factor: 0.144

2.  Immunoglobulins and circulating immune complexes in nephrotic syndrome.

Authors:  O P Mishra; R Garg; Z Ali; B K Das
Journal:  J Trop Pediatr       Date:  1997-04       Impact factor: 1.165

3.  Serum IgG, IgA and IgM levels of children with idiopathic nephrotic syndrome and response to corticosteroids.

Authors:  B K Das; S Kumar; M R Sen; O P Mishra
Journal:  J Trop Pediatr       Date:  1994-06       Impact factor: 1.165

4.  Letter: Lymphokines and nephrotic syndrome.

Authors:  G Lagrue; S Xheneumont; A Branellec; B Weil
Journal:  Lancet       Date:  1975-02-01       Impact factor: 79.321

5.  Time trends and ethnic patterns of childhood nephrotic syndrome in Yorkshire, UK.

Authors:  P A McKinney; R G Feltbower; J T Brocklebank; M M Fitzpatrick
Journal:  Pediatr Nephrol       Date:  2001-12       Impact factor: 3.714

6.  Clinicopathological features of childhood nephrotic syndrome in northern Nigeria.

Authors:  M B Abdurrahman; H A Aikhionbare; F A Babaoye; N Sathiakumar; P T Narayana
Journal:  Q J Med       Date:  1990-06

7.  Altered expression of B lymphocyte surface immunoglobulins in minimal change nephrotic syndrome and focal glomerulosclerosis.

Authors:  P Dall'Aglio; P L Meroni; W Barcellini; C Brigati; C Chizzolini; G De Bartolo; L Migone; C Zanussi
Journal:  Nephron       Date:  1984       Impact factor: 2.847

8.  Serum immunoglobulins in minimal change nephrotic syndrome--a possible defect in T-cell function.

Authors:  H Rashid; A W Skillen; A R Morley; D N Kerr
Journal:  Bangladesh Med Res Counc Bull       Date:  1982-06

9.  Enhanced suppressor T cell activity resulting in increased IgM and decreased IgG productions in children with minimal change nephrotic syndrome.

Authors:  C H Chen; K H Hsieh; P P Lee
Journal:  Int J Pediatr Nephrol       Date:  1987 Apr-Jun

10.  The primary nephrotic syndrome in children. Identification of patients with minimal change nephrotic syndrome from initial response to prednisone. A report of the International Study of Kidney Disease in Children.

Authors: 
Journal:  J Pediatr       Date:  1981-04       Impact factor: 4.406

View more
  6 in total

1.  Toll-like receptor 3 expression and function in childhood idiopathic nephrotic syndrome.

Authors:  A Jamin; L Dehoux; C Dossier; M Fila; N Heming; R C Monteiro; G Deschênes
Journal:  Clin Exp Immunol       Date:  2015-09-30       Impact factor: 4.330

2.  Clinical significance of T lymphocyte subsets, immunoglobulin and complement expression in peripheral blood of children with steroid-dependent nephrotic syndrome/frequently relapsing nephrotic syndrome.

Authors:  Shulian Chen; Jianxin Wang; Shishan Liang
Journal:  Am J Transl Res       Date:  2021-03-15       Impact factor: 4.060

3.  Prediction of steroid response in nephrotic syndrome by humoral immunity assessment.

Authors:  D M Youssef; S M Abdel Salam; R A Karam
Journal:  Indian J Nephrol       Date:  2011-07

4.  Immunoglobulin G and M levels in childhood nephrotic syndrome: two centers Egyptian study.

Authors:  Ghada Mohamed El Mashad; Soha Abd El Hady Ibrahim; Sameh Abd Allah Abdelnaby
Journal:  Electron Physician       Date:  2017-02-25

5.  Establishment of relapse risk model and multivariate logistic regression analysis on risk factors of relapse in children with primary nephrotic syndrome.

Authors:  Qian-Qian Peng; Ping Zeng; Xiao-Hua Jiang; Feng-Jun Guan
Journal:  Medicine (Baltimore)       Date:  2022-07-22       Impact factor: 1.817

Review 6.  Efficacy and safety of Huaiqihuang granule as adjuvant treatment for primary nephrotic syndrome in children: a meta-analysis and systematic review.

Authors:  Jiao Lin; Li-Min Huang; Jing-Jing Wang; Jian-Hua Mao
Journal:  World J Pediatr       Date:  2021-06-01       Impact factor: 2.764

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.